BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 23, Issue 11
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16517)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.
Item 
Count 
PDF2561
WORD244
HTML11100
Figures (1-1)178
Tables (1-4)162
 Sum=14245
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1060
Download1212
 Sum=2272
Mar 21, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World J Gastroenterol 2017; 23(11): 1954-1963 [PMID: 28373761 DOI: 10.3748/wjg.v23.i11.1954]
URL: https://www.wjgnet.com/1007-9327/full/v23/i11/1954.htm
Number Citing Articles
1
Annie M. Young, Andrea Marshall, Jenny Thirlwall, Oliver Chapman, Anand Lokare, Catherine Hill, Danielle Hale, Janet A. Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay Kakkar, F.D. Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher J. Poole, Anthony Maraveyas, Mark Levine. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). Journal of Clinical Oncology 2018; 36(20): 2017 doi: 10.1200/JCO.2018.78.8034
2
Kristína Grilusová, Tomáš Bolek, Ingrid Škorňová, Lucia Stančiaková, Veronika Mikušová, Peter Kubisz, Peter Galajda, Ján Staško, Matej Samoš, Marián Mokáň. Apixaban: An Optimal Agent for the Treatment of Cancer-Associated Venous Thromboembolism?. American Journal of Therapeutics 2022; 29(2): e212 doi: 10.1097/MJT.0000000000001451
3
Olga D. Ostroumova, Aleksey I. Kochetkov, Svetlana V. Batyukina, Sergey V. Cheremushkin. Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A review. Consilium Medicum 2023; 25(5): 368 doi: 10.26442/20751753.2023.5.202294
4
Juan Pablo Salazar Adum, Iva Golemi, Luis H. Paz, Luis Diaz Quintero, Alfonso J. Tafur, Joseph A. Caprini. Venous thromboembolism controversies. Disease-a-Month 2018; 64(9): 408 doi: 10.1016/j.disamonth.2018.03.003
5
Mei-na Lv, Xiao-chun Zheng, Hong-qin Zhang, Fang-da Xu, Ting-ting Wu, Wen-jun Chen, Xiao-tong Xia, Jing-lan Fu, Shao-jun Jiang, Jin-hua Zhang. Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants. Journal of Thrombosis and Thrombolysis 2021; 51(1): 136 doi: 10.1007/s11239-020-02152-1
6
Diego F. Rodríguez, Francisca Durán-Osorio, Yorley Duarte, Pedro Olivares, Yanina Moglie, Kamal Dua, Flavia C. Zacconi. Green by Design: Convergent Synthesis, Computational Analyses, and Activity Evaluation of New FXa Inhibitors Bearing Peptide Triazole Linking Units. Pharmaceutics 2021; 14(1): 33 doi: 10.3390/pharmaceutics14010033
7
Fang Jiang, Chengsheng Ju, Chuan‐Guo Guo, Ka Shing Cheung, Bofei Li, Simon Y. K. Law, Wallis C. Y. Lau, Wai K. Leung. Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population‐based cohort study. Helicobacter 2023; 28(4) doi: 10.1111/hel.12990
8
Taishi HATA. Venous thromboembolism (VTE) in gastrointestinal cancer treatment. Japanese Journal of Thrombosis and Hemostasis 2023; 34(5): 584 doi: 10.2491/jjsth.34.584
9
森山 直紀 (Naoki Moriyama), 当麻 美樹 (Yoshiki Tohma), 川嶋 太郎 (Taro Kawashima), 國重 千佳 (Chika Kunishige), 小野 雄一郎 (Yuichiro Ono), 高橋 晃 (Akira Takahashi), 佐野 秀 (Shigeru Sano). ダビガトラン内服中に生じた広範囲結腸粘膜下出血により結腸亜全摘を余儀なくされた1例(A case of subtotal colectomy caused by dabigatran–associated extensive intramural hemorrhage of the colon). Nihon Kyukyu Igakukai Zasshi: Journal of Japanese Association for Acute Medicine 2019; 30(5): 146 doi: 10.1002/jja2.12363
10
Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y. H. Lip. Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. Therapeutic Advances in Gastroenterology 2021; 14: 175628482199735 doi: 10.1177/1756284821997352
11
Massimiliano Camilli, Marco Lombardi, Giovanni Maria Vescovo, Marco Giuseppe Del Buono, Mattia Galli, Nadia Aspromonte, Giuseppe Biondi Zoccai, Giampaolo Niccoli, Rocco A. Montone, Filippo Crea, Giorgio Minotti. Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2020; 154: 103074 doi: 10.1016/j.critrevonc.2020.103074
12
A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Yu. V. Kotovskaya. Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding. Safety and Risk of Pharmacotherapy 2019; 7(2): 65 doi: 10.30895/2312-7821-2019-7-2-65-71
13
O. D. Ostroumova, E. A. Volkova, A. I. Kochetkov, A. P. Pereverzev, O. N. Tkacheva. Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors. Cardiovascular Therapy and Prevention 2019; 18(5): 128 doi: 10.15829/1728-8800-2019-5-128-137
14
Doris Barcellona, L. Fenu, F. Marongiu. Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants. International Journal of Cardiology 2021; 339: 134 doi: 10.1016/j.ijcard.2021.07.029
15
Arnar B. Ingason, Johann P. Hreinsson, Arnar S. Agustsson, Sigrun H. Lund, Edward Rumba, Daniel A. Palsson, Indridi E. Reynisson, Brynja R. Gudmundsdottir, Pall T. Onundarson, Einar S. Bjornsson. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study. Clinical Gastroenterology and Hepatology 2023; 21(2): 347 doi: 10.1016/j.cgh.2022.06.033
16
Jang Ho Lee, Dalsan You, Sang-Do Lee, Yeon-Mok Oh, Jae Seung Lee. A Study on the Efficacy and Safety of Rivaroxaban in Urologic Cancer-Associated Venous Thromboembolism. The Korean Journal of Urological Oncology 2019; 17(3): 178 doi: 10.22465/kjuo.2019.17.3.178
17
Mostafa El Mokadem, Ahmed Hassan, Abdulaziz Z Algaby. Efficacy and safety of apixaban in patients with active malignancy and acute deep venous thrombosis. Vascular 2021; 29(5): 745 doi: 10.1177/1708538120971148
18
Ritika Halder, Eric Brucks, Ce Cheng, Kathylynn Saboda, Hani M. Babiker, Ali Mcbride, Alejandro Recio-Boiles. Retrospective real-world meta-analysis of high-risk major bleeding as a primary safety outcome in cancer patients receiving therapeutic anticoagulation. Thrombosis Update 2022; 9: 100121 doi: 10.1016/j.tru.2022.100121
19
Gilles Lemesle, Christophe Bauters, Laurent Bonello, Laurent Fauchier, Guillaume Cayla, Eloi Marijon, Maxime Guenoun, Guillaume Schurtz, Sandro Ninni, Marjorie Richardson, Franck Albert, Serge Cohen, Nicolas Lamblin, Nicolas Danchin. Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation. International Journal of Cardiology 2022; 348: 15 doi: 10.1016/j.ijcard.2021.11.077
20
Chun En Yau, Chen Ee Low, Natasha Yixuan Ong, Sounak Rana, Lucas Jun Rong Chew, Sara Moiz Tyebally, Ping Chai, Tiong-Cheng Yeo, Mark Y. Chan, Matilda Xinwei Lee, Li-Ling Tan, Chieh-Yang Koo, Ainsley Ryan Yan Bin Lee, Ching-Hui Sia. Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis. Cancers 2023; 15(24): 5887 doi: 10.3390/cancers15245887
21
Sung Hee Youn, Hyun Lim, Yeonmi Ju, Jae Seung Soh, Ji Won Park, Ho Suk Kang, Sung Eun Kim, Sung Hoon Moon, Jong Hyeok Kim, Choong Kee Park, Seung In Seo, Woon Geon Shin. Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulants. Scandinavian Journal of Gastroenterology 2018; 53(12): 1490 doi: 10.1080/00365521.2018.1541478
22
Jang Ho Lee, Joo Hee Lee, Kyung-Wook Jo, Jin-Won Huh, Yeon-Mok Oh, Jae Seung Lee. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers. Journal of Gynecologic Oncology 2020; 31(1) doi: 10.3802/jgo.2020.31.e10
23
Rohan Stuart Smith, Stephanie Wei Jia Tan, Genevieve Ann Heath‐Kalgutkar, Vu Hoang Tran, Ashray Rajagopalan, Tim Buckenham. Factors predicting positive CT mesenteric angiography results in lower gastrointestinal haemorrhage prior to consideration of intra‐arterial angio‐embolisation. Journal of Medical Imaging and Radiation Oncology 2021; 65(7): 841 doi: 10.1111/1754-9485.13176
24
Tadakiyo Ido, Shun Sasaki, Yohei Sotomi, Akio Hirata, Nobuhiko Makino, Takaharu Hayashi, Yasushi Sakata, Atsushi Hirayama, Yoshiharu Higuchi. Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation. American Heart Journal Plus: Cardiology Research and Practice 2022; 22: 100203 doi: 10.1016/j.ahjo.2022.100203
25
Hanno Riess, Peter Verhamme, Jeffrey I. Weitz, Annie Young, Rupert Bauersachs, Jan Beyer-Westendorf, Mark Crowther, Anthony Maraveyas. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Critical Reviews in Oncology/Hematology 2021; 157: 103125 doi: 10.1016/j.critrevonc.2020.103125
26
Kathlyne Jayne B. Bautista, Jinwook Kim, Zhen Xu, Xiaoning Jiang, Paul A. Dayton. Current Status of Sub-micron Cavitation-Enhancing Agents for Sonothrombolysis. Ultrasound in Medicine & Biology 2023; 49(5): 1049 doi: 10.1016/j.ultrasmedbio.2023.01.018
27
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World Journal of Cardiology 2023; 15(8): 375-394 doi: 10.4330/wjc.v15.i8.375
28
M. Hennessy, B. Reidy, F. Ní Ainle, J. Conneely, C. McDermott, P. Ó. Scanaill. Supratherapeutic dabigatran: a cause of life‐threatening haemorrhage*. Anaesthesia Reports 2023; 11(1) doi: 10.1002/anr3.12208
29
E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva. Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature). The Scientific Notes of the Pavlov University 2020; 26(3): 43 doi: 10.24884/1607-4181-2019-26-3-43-56
30
Rosa Purgatorio, Nicola Gambacorta, Francesco Samarelli, Gianfranco Lopopolo, Modesto de Candia, Marco Catto, Orazio Nicolotti, Cosimo D. Altomare. Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases. Molecules 2022; 27(13): 4269 doi: 10.3390/molecules27134269
31
Ibrahim Halil Inanc, Saadet Kılıc, Murat Polat. Rivaroxaban induced spontaneous hemoperitoneum around terminal ileum and cecum clinically mimicking acute appendicitis in a young patient: First case report. Journal of Clinical Medicine of Kazakhstan 2020; 2(56): 50 doi: 10.23950/1812-2892-JCMK-00756
32
Tomonari Shimoda, Atsuyuki Watanabe. Apixaban for Atrial Fibrillation and Systemic Fluconazole: Bleeding Risk and Possible Preventative Measures. The American Journal of Medicine 2022; 135(10): e406 doi: 10.1016/j.amjmed.2022.05.023
33
Anders Holt, Paul Blanche, Bochra Zareini, Peter Vibe Rasmussen, Jarl Emanuel Strange, Deepthi Rajan, Mads Hashiba Jensen, Mohammed El-Sheikh, Anne-Marie Schjerning, Morten Schou, Gunnar Gislason, Christian Torp-Pedersen, Patricia McGettigan, Morten Lamberts. Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants. Heart 2022; 108(8): 626 doi: 10.1136/heartjnl-2021-319503
34
J. Starup-Linde, B. Langdahl, P. Vestergaard, T. Harsløf. Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study. Osteoporosis International 2022; 33(6): 1323 doi: 10.1007/s00198-022-06315-z
35
Laura M Attard, Alex Gatt, Laurent Bertoletti, Aurelien Delluc, Nicoletta Riva. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. Vascular Health and Risk Management 2022; : 793 doi: 10.2147/VHRM.S271411
36
Ken Ohata, Eiji Sakai, Yuichiro Suzuki, Shunya Takayanagi, Marie Kurebayashi, Yoshiaki Kimoto, Rindo Ishii, Takafumi Konishi, Kohei Ono, Tomoya Hirata, Keisuke Kanda, Maiko Takita, Ryoju Negishi, Yohei Minato, Takashi Muramoto, Hitoshi Satodate, Masataka Taguri, Nobuyuki Matsuhashi. Risk factors of delayed bleeding after endoscopic resection of superficial non‐ampullary duodenal epithelial tumors and prevention by over‐the‐scope and conventional clipping. Digestive Endoscopy 2021; 33(3): 390 doi: 10.1111/den.13729
37
Daniel Wadsworth, Emma Sullivan, Thomas Jacky, Taylor Sprague, Hannah Feinman, Jennifer Kim. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant. Journal of Clinical Pharmacy and Therapeutics 2021; 46(3): 560 doi: 10.1111/jcpt.13343
38
Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu, Shuang Zhou, Hanxu Zhang, Zining Wang, Jie Jiang, Kun Hu, Yatong Zhang, Zinan Zhao, Dongdong Yuan, Liping Guo, Tingting Wu, Jinhua Zhang, Na Wang, Jing Xiang, Zhichun Gu, Jianjun Sun, Yimin Cui. Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study. Clinical and Translational Medicine 2023; 13(5) doi: 10.1002/ctm2.1263
39
Ruchi Desai, Gautam Krishna Koipallil, Nelson Thomas, Rahul Mhaskar, Nathan Visweshwar, Damian Laber, Ankita Patel, Michael Jaglal. Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75863-3
40
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALHAES, Décio CHINZON, Marcelo CURY, Gerson DOMINGUES, Jorge Luiz JORGE, Ismael MAGUILNIK, Frederico Passos MARINHO, Joaquim Prado de MORAES-FILHO, José Miguel Luz PARENTE, Celso Mirra de PAULA-E-SILVA, José PEDRAZZOLI-JÚNIOR, Ana Flávia Passos RAMOS, Heinrich SEIDLER, José Nonato SPINELLI, José Vitor ZIR. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arquivos de Gastroenterologia 2018; 55(2): 97 doi: 10.1590/s0004-2803.201800000-20
41
Dan Zhang, Wei Qin, Wenwen Du, Xiaoxing Wang, Wenqian Chen, Pengmei Li. Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non‐valvular atrial fibrillation. Biopharmaceutics & Drug Disposition 2022; 43(4): 163 doi: 10.1002/bdd.2327
42
Arnar B. Ingason, Johann P. Hreinsson, Einar S. Björnsson. Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known. Drug Safety 2022; 45(12): 1449 doi: 10.1007/s40264-022-01243-7
43
N. M. Vorobyeva, O. N. Tkacheva. Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding. Rational Pharmacotherapy in Cardiology 2023; 19(1): 101 doi: 10.20996/1819-6446-2023-01-02
44
Hyung Hwan Moon. Refractory Ascites with Intrahepatic Portal Thrombosis after Living Donor Liver Transplantation Successfully Treated by Splenic Artery Embolization and Apixaban (Case Report). Kosin Medical Journal 2021; 36(2): 187 doi: 10.7180/kmj.2021.36.2.187
45
Lubomir Mihalkanin, Branislav Stancak. The Impact of Novel Anticoagulants on the Upper Gastrointestinal Tract Mucosa. Medicina 2020; 56(7): 363 doi: 10.3390/medicina56070363
46
Ju Yup Lee. Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(4): 219 doi: 10.7704/kjhugr.2018.18.4.219
47
Jakub Z. Qazi, Mireille E. Schnitzer, Robert Côté, Marie-Josée Martel, Marc Dorais, Sylvie Perreault, Gianluigi Savarese. Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge. PLOS ONE 2021; 16(3): e0246691 doi: 10.1371/journal.pone.0246691
48
Ya-Ling Huang, Ching-Yao Chen, Ching-Chi Chu. Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin. International Journal of Clinical Pharmacy 2022; 44(1): 34 doi: 10.1007/s11096-021-01309-z
49
Parita Patel, Neil Sengupta. PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19. Digestive Diseases and Sciences 2020; 65(8): 2181 doi: 10.1007/s10620-020-06408-x
50
Sreeram V Ramagopalan, Mihail Samnaliev, Sharada Weir, Cormac J Sammon, Robert Carroll, Raza Alikhan. Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study. Future Cardiology 2019; 15(5): 367 doi: 10.2217/fca-2019-0033
51
N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya. Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy. Russian Journal of Cardiology 2021; 26(8): 4635 doi: 10.15829/1560-4071-2021-4635
52
Charles J. Ferro, Fay Solkhon, Zahraa Jalal, Abdullah M. Al‐Hamid, Alan M. Jones. Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulants. Pharmacology Research & Perspectives 2020; 8(3) doi: 10.1002/prp2.603
53
Ivan David Lozada Martinez, Luis Carlos Solano Díaz, Marcela Barbosa Pérez, Víctor Andrés Rueda Oviedo, Brainerd Lenin Caicedo Moncada, Gustavo Andrés Diaz Cruz, Adriana cristina Ceballos Espitia, David Esteban Diaz Gómez, Daiana Andrea Rojas Ramírez . Riesgo de sangrado gastrointestinal por uso de anticoagulantes directos orales: ¿cuál es más seguro?. Revista Cuarzo 2022; 28(2): 31 doi: 10.26752/cuarzo.v28.n2.656
54
Meghdad Sedaghat, Behnam Safarpour Lima, Reihanesadat Bouzari, Sarvenaz Shadlou. Gastrointestinal Bleeding Associated With Warfarin and Rivaroxaban Therapy in Atrial Fibrillation Cases with Concomitant Coagulopathy. Cardiovascular & Hematological Disorders-Drug Targets 2021; 21(2): 123 doi: 10.2174/1871529X20999201231210044
55
Gregory Y. H. Lip, Allison V. Keshishian, Yan Zhang, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Huseyin Yuce, Steven Deitelzweig. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding. JAMA Network Open 2021; 4(8): e2120064 doi: 10.1001/jamanetworkopen.2021.20064
56
Vítor Macedo Silva, Marta Freitas, Cátia Arieira, Sofia Xavier, Pedro Boal Carvalho, Bruno Rosa, Maria João Moreira, José Cotter. Direct oral anticoagulants are associated with potentially bleeding lesions in suspected mid-gastrointestinal bleeding. Scandinavian Journal of Gastroenterology 2022; 57(4): 486 doi: 10.1080/00365521.2021.2014951
57
Veronica Ojetti, Angela Saviano, Mattia Brigida, Luisa Saviano, Alessio Migneco, Francesco Franceschi. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding. Reviews on Recent Clinical Trials 2021; 15(4): 309 doi: 10.2174/1574887115666200624193938
58
Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, Valeria Coluccio, Alessandra Marrazzo, Afroditi Athanasiou, Maria Di Girolamo, Cinzia Cappi, Marco Marietta, Mariano Capitelli. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review. Advances in Therapy 2023; 40(1): 41 doi: 10.1007/s12325-022-02333-9
59
Vladimir V. Yurukov, Tracy Boykin, Megan A. Rech. Tranexamic Acid for the Treatment of Acute Gastrointestinal Bleeding in a Jehovah's Witness Patient on Apixaban and Dual Antiplatelet Therapy. Advanced Emergency Nursing Journal 2022; 44(1): 11 doi: 10.1097/TME.0000000000000386
60
Xinkang Wang, Qiu Li, Fuyong Du, Neetu Shukla, Andrea R. Nawrocki, Madhu Chintala. Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis. TH Open 2023; 7(02): e97 doi: 10.1055/a-2061-3311
61
Yu Jia, Shao-Hua Wang, Na-Juan Cui, Quan-Xi Liu, Wei Wang, Xue Li, Ya-Mei Gu, Yan Zhu. Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report. World Journal of Clinical Cases 2022; 10(8): 2537-2542 doi: 10.12998/wjcc.v10.i8.2537
62
Kaori Ambe, Ayu Akita, Jie Wei, Yuka Yoshii, Mayu Onishi, Masahiro Tohkin. Comparison of Efficacy and Safety of Direct Oral Anticoagulants and Warfarin between Patients in Asian and Non‐Asian Regions: A Systematic Review and Meta‐Regression Analysis. Clinical Pharmacology & Therapeutics 2023; 113(6): 1240 doi: 10.1002/cpt.2881
63
So-Ryoung Lee, Soonil Kwon, Eue-Keun Choi, Jin-Hyung Jung, Kyung-Do Han, Seil Oh, Gregory Y. H. Lip. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding. Cardiovascular Drugs and Therapy 2022; 36(4): 679 doi: 10.1007/s10557-021-07170-6
64
Melina Verso, Michela Giustozzi, Alessandra Vinci, Laura Franco, Maria Cristina Vedovati, Emanuela Marchesini, Cecilia Becattini, Giancarlo Agnelli. Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding. Thrombosis Research 2021; 208: 138 doi: 10.1016/j.thromres.2021.10.022
65
Giulio Francesco Romiti, Bernadette Corica, Marco Proietti. A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long story. Future Cardiology 2021; 17(2): 215 doi: 10.2217/fca-2020-0084
66
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva. Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(3): 14 doi: 10.22416/1382-4376-2020-30-3-14-23
67
Yi Ren, Shi-Liang Cao, Zeng Li, Tim Luo, Bin Feng, Xi-Sheng Weng. Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial. Chinese Medical Journal 2021; 134(2): 164 doi: 10.1097/CM9.0000000000001305
68
Xiaoli Wang, Shuo Wang, Michael A. Morse, Ni Jiang, Yanjie Zhao, Yuguang Song, Lei Zhou, Hongyan Huang, Xinna Zhou, Amy Hobeika, Jun Ren, Herbert Kim Lyerly. Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients. Journal of Thrombosis and Thrombolysis 2019; 47(4): 505 doi: 10.1007/s11239-019-01844-7
69
Ryan Dunn, Nishant Sahni. 62-Year-Old Man With Abdominal Pain. Mayo Clinic Proceedings 2023; 98(2): 337 doi: 10.1016/j.mayocp.2022.06.033
70
Rachel Ryu, Rebecca Tran. DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions. Clinical and Applied Thrombosis/Hemostasis 2022; 28: 107602962211035 doi: 10.1177/10760296221103578
71
Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin-Hyung Jung, Kyung-Do Han, Myung-Jin Cha, Seil Oh, Gregory Y.H. Lip. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding. Stroke 2021; 52(2): 511 doi: 10.1161/STROKEAHA.120.030761
72
Judith Catella, Laurent Bertoletti, Farès Moustafa, José Antonio Nieto, Reina Valle, José María Pedrajas, Aurora Villalobos, Isabelle Quere, Gabrielle Sarlon-Bartoli, Manuel Monreal. Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism. Thrombosis Research 2022; 214: 29 doi: 10.1016/j.thromres.2022.04.005
73
Ka-Shing Cheung, Wai K Leung, Wai-Kay Seto. Application of Big Data analysis in gastrointestinal research. World Journal of Gastroenterology 2019; 25(24): 2990-3008 doi: 10.3748/wjg.v25.i24.2990
74
Meixiang Yu, Zi Wang, Liuliu Zong, Qing Xu, Xiaoye Li, Qianzhou Lv. A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation. International Journal of Clinical Pharmacy 2022; 44(5): 1149 doi: 10.1007/s11096-022-01443-2
75
Xiangji Dang, Zhilong Liu, Xiaoyun Sheng, Yan Liu. Apply Anticoagulants after Discharge not Benefit to the Incidence of Symptomatic Thrombus in High‐Altitude Areas: A Retrospective Study. Orthopaedic Surgery 2023; 15(12): 3118 doi: 10.1111/os.13888
76
Maurizio Giuseppe Abrignani, Luigi Gatta, Domenico Gabrielli, Giuseppe Milazzo, Vincenzo De Francesco, Leonardo De Luca, Maura Francese, Massimo Imazio, Elisabetta Riccio, Roberta Rossini, Fortunato Scotto di Uccio, Marco Soncini, Angelo Zullo, Furio Colivicchi, Andrea Di Lenarda, Michele Massimo Gulizia, Fabio Monica. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). European Journal of Internal Medicine 2021; 85: 1 doi: 10.1016/j.ejim.2020.11.014
77
Andrew N. Fleischman, William T. Li, Andrew J. Luzzi, Duncan S. Van Nest, Marc C. Torjman, Eric S. Schwenk, William A. Arnold, Javad Parvizi. Risk of Gastrointestinal Bleeding With Extended Use of Nonsteroidal Anti-Inflammatory Drug Analgesia After Joint Arthroplasty. The Journal of Arthroplasty 2021; 36(6): 1921 doi: 10.1016/j.arth.2021.02.015
78
Meina Lv, Shaojun Jiang, Tingting Wu, Nianxu Huang, Xia Chen, Chunmei Chen, Jinhua Zhang. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban). British Journal of Clinical Pharmacology 2023; 89(1): 253 doi: 10.1111/bcp.15491
79
Pranjal Kumar Singh, T.S. Easwari. Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and Techniques. Current Drug Therapy 2022; 17(1): 2 doi: 10.2174/1574885517666220307115813
80
Shujuan Zhao, Xuejiao Hong, Jingjing Cao, Haixia Cai, Song Du, Peizhi Ma. Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01293
81
Sharon Wei, Aanchal Sawhney, Harshwardhan Khandait, Amit Meda, Vasu Gupta, Rohit Jain. An update on applications and limitations of direct oral anticoagulants. The Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00212-5
82
So-Ryoung Lee, Hyo-Jeong Ahn, Eue-Keun Choi, Sang-Hyun Park, Kyung-Do Han, Seil Oh, Gregory Y.H. Lip. Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort Study. Clinical Gastroenterology and Hepatology 2024; 22(5): 981 doi: 10.1016/j.cgh.2023.12.022
83
E. V. Moroz, A. Y. Karateev, E. V. Kryukov, A. A. Sokolov, E. N. Artemkin. Comparison of the Endoscopic Picture in Case of Complications of the upper Gastrointestinal Tract Caused by the Use of Antithrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 2019; 4(5): 19 doi: 10.29413/ABS.2019-4.5.3
84
Tarek Nammour, Lara El Jamal, Mohammad N. Hosni, Hani Tamim, Anthony Kerbage, Jana G. Hashash, Yasser H. Shaib, Fady Daniel, Fadi Francis, Fadi H. Mourad, Assaad Soweid, Ala I. Sharara, Maha Makki, Don C. Rockey, Kassem Barada. Development and Validation of a Novel 1-year Mortality Risk Score That Includes the Use of Antithrombotic in Patients With Overt Gastrointestinal Bleeding. Journal of Clinical Gastroenterology 2023; 57(7): 700 doi: 10.1097/MCG.0000000000001736
85
Gianni Turcato, Antonio Bonora, Elisabetta Zorzi, Arian Zaboli, Massimo Zannoni, Giorgio Ricci, Norbert Pfeifer, Antonio Maccagnani, Andrea Tenci. Thirty-day mortality in atrial fibrillation patients with gastrointestinal bleeding in the emergency department: differences between direct oral anticoagulant and warfarin users. Internal and Emergency Medicine 2020; 15(2): 311 doi: 10.1007/s11739-019-02229-7
86
David M. Richards, Sajini Thekkel, William A. Ross. Oncologic Critical Care. 2020; : 869 doi: 10.1007/978-3-319-74588-6_176
87
Yunyun Diao, Zhenzhou Zhang, Osamah Ibrahim Khalaf. Dictionary Learning-Based Ultrasound Image Combined with Gastroscope for Diagnosis of Helicobacter pylori-Caused Gastrointestinal Bleeding. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/6598631
88
Martin Müller, Jonathan Eastline, Michael Nagler, Aristomenis K. Exadaktylos, Thomas C. Sauter. Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2019; 27(1) doi: 10.1186/s13049-019-0625-3
89
Nanda Kandamany, Heather Tan. Novel oral anticoagulant induced upper limb haematoma: A case report. JPRAS Open 2018; 16: 20 doi: 10.1016/j.jpra.2017.08.008
90
Yuxin Xie, Liya Zhu, Zebin Wang, Xiaojiang Zhan, Fenfen Peng, Xiaoran Feng, Qian Zhou, Xianfeng Wu, Xiaoyang Wang, Ning Su, Xingming Tang, Yujing Zhang, Yingsi Zeng, Mengmeng Li, Jianbo Liang, Lingling Liu, Yueqiang Wen. ACEi/ARBs associate with lower incidence of gastrointestinal bleeding in peritoneal dialysis patients. Clinical and Experimental Nephrology 2022; 26(3): 278 doi: 10.1007/s10157-021-02150-4
91
Larisa Anghel, Radu Sascău, Anca Trifan, Ioana Mădălina Zota, Cristian Stătescu. Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies. Journal of Clinical Medicine 2020; 9(5): 1398 doi: 10.3390/jcm9051398
92
Muhammad A. Shafqet, Alexander Tonthat, Paola Esparragoza, Butros Toro, Adam C. Ehrlich, Frank K. Friedenberg. Recent use of NSAID and NOAC medications are associated with a positive CT arteriogram. Abdominal Radiology 2019; 44(7): 2632 doi: 10.1007/s00261-019-02005-3
93
Sampada K. Gandhi, James A. Reiffel, Rania Boiron, Mattias Wieloch. Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database). The American Journal of Cardiology 2021; 159: 79 doi: 10.1016/j.amjcard.2021.08.015
94
Matthew C. Dallos, Andrew B. Eisenberger, Susan E. Bates. Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical Dilemma. The Oncologist 2020; 25(2): 132 doi: 10.1634/theoncologist.2019-0264
95
Victoria R Nachar, Allison J Schepers. Clinical controversies in the treatment of cancer-associated venous thromboembolism. Journal of Oncology Pharmacy Practice 2021; 27(4): 939 doi: 10.1177/1078155220984371
96
Ian Lancaster, Vikas Sethi, Deep Patel, Cyrus Tamboli, Elizabeth Pacer, Jeffrey Steinhoff, Meir Mizrahi, Andrew Willinger. Antithrombotics and Gastrointestinal Prophylaxis: A Systematic Review. Cardiology in Review 2023;  doi: 10.1097/CRD.0000000000000543
97
Yuji Murakami, Masahiro Kenjo, Kazuki Ishikawa, Toru Sakayauchi, Satoshi Itasaka, Yoshiharu Negoro, Keiichi Jingu, Yasumasa Nishimura, Yasushi Nagata, Kazuhiko Ogawa. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents. Journal of Radiation Research 2020; 61(4): 629 doi: 10.1093/jrr/rraa035
98
Christoph Sucker, Jens Litmathe, Heiner K. Berthold. Orale Antikoagulation bei Vorhofflimmern. MMW - Fortschritte der Medizin 2019; 161(S6): 15 doi: 10.1007/s15006-019-0920-y
99
Fernando Carballo Álvarez, Agustín Albillos Martínez, Pilar Llamas Silero, Aitor Orive Calzada, Eduardo Redondo-Cerezo, Enrique Rodríguez de Santiago, Javier Crespo García. Consensus document of the Sociedad Española de Patología Digestiva on massive nonvariceal gastrointestinal bleeding and direct-acting oral anticoagulants. Revista Española de Enfermedades Digestivas 2022;  doi: 10.17235/reed.2022.8920/2022
100
Anna W. Boone, Chelsea L. Carlan, Leslie S. Lewis. Overt Small Bowel Bleeding in the Older Adult. The Journal for Nurse Practitioners 2023; 19(1): 104460 doi: 10.1016/j.nurpra.2022.09.013
101
Tatsuya Sakamoto, Tsutomu Nishida, Dai Nakamatsu, Asuka Watanabe, Takao Kitanaka, Yutaro Minoura, Kana Hosokawa, Satoru Okabe, Naohiro Sakamoto, Yoshifumi Fujii, Naoto Osugi, Aya Sugimoto, Kengo Matsumoto, Shiro Hayashi, Sachiko Nakajima, Masashi Yamamoto. Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohort. Asia-Pacific Journal of Clinical Oncology 2023;  doi: 10.1111/ajco.13954
102
Yujing Zhou, Chunhua Liu, Yongcan Huang. Wireless Power Transfer for Implanted Medical Application: A Review. Energies 2020; 13(11): 2837 doi: 10.3390/en13112837
103
Stefano Ballestri, Mariano Capitelli, Maria Cristina Fontana, Dimitriy Arioli, Elisa Romagnoli, Catia Graziosi, Amedeo Lonardo, Marco Marietta, Francesco Dentali, Giorgio Cioni. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Advances in Therapy 2020; 37(5): 1910 doi: 10.1007/s12325-020-01307-z
104
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva. Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive Options. Kardiologiia 2020; 60(7): 125 doi: 10.18087/cardio.2020.7.n942
105
Petrica Popa, Sevastita Iordache, Dan Nicolae Florescu, Vlad Florin Iovanescu, Alexandru Vieru, Valentin Barbu, Maria-Cristina Bezna, Dragos Ovidiu Alexandru, Bogdan Silviu Ungureanu, Sergiu Marian Cazacu. Mortality Rate in Upper Gastrointestinal Bleeding Associated with Anti-Thrombotic Therapy Before and During Covid-19 Pandemic. Journal of Multidisciplinary Healthcare 2022; : 2679 doi: 10.2147/JMDH.S380500
106
Jean Terrier, Youssef Daali, Pierre Fontana, Chantal Csajka, Jean-Luc Reny. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants. Clinical Pharmacokinetics 2019; 58(12): 1517 doi: 10.1007/s40262-019-00792-y
107
A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son. New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 7 doi: 10.22416/1382-4376-2020-30-2-7-14
108
Martin Müller, Michaela Traschitzger, Michael Nagler, Spyridon Arampatzis, Aristomenis K. Exadaktylos, Thomas C. Sauter. Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants. BMC Emergency Medicine 2021; 21(1) doi: 10.1186/s12873-021-00497-1
109
Anne-Céline Martin, Robert Benamouzig, Isabelle Gouin-Thibault, Jeannot Schmidt. Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion. American Journal of Cardiovascular Drugs 2023; 23(4): 407 doi: 10.1007/s40256-023-00582-9
110
Parata Chaiyana, Karjpong Techathuvanan, Supatsri Sethasine. Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44494-9
111
Asra Batool, Rosa T. Bui. Management of Occult GI Bleeding. Clinical Gastroenterology 2021; : 251 doi: 10.1007/978-3-030-71468-0_15
112
Anders Holt, Jarl E. Strange, Nina Nouhravesh, Patricia McGettigan, Morten Lamberts. The Reply. The American Journal of Medicine 2022; 135(10): e407 doi: 10.1016/j.amjmed.2022.06.008
113
Maseray S. Kamara, Choichi Sugawa. Case report: An unusual case of cecal mucosal bleeding. JGH Open 2023; 7(1): 72 doi: 10.1002/jgh3.12826
114
E. V. Moroz, E. N. Artemkin, E. V. Kryukov, V. A. Chernetsov. Gastro-Intestinal Tract Complications During Antithrombotic Therapy. General Reanimatology 2018; 14(3): 15 doi: 10.15360/1813-9779-2018-3-15-26
115
Dorotea Bozic, Damir Alicic, Dinko Martinovic, Ivan Zaja, Josipa Bilandzic-Ivisic, Rosana Sodan, Branka Kresic, Andre Bratanic, Zeljko Puljiz, Zarko Ardalic, Josko Bozic. Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study. Medicina 2023; 59(8): 1466 doi: 10.3390/medicina59081466
116
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001. Zeitschrift für Gastroenterologie 2023; 61(05): 544 doi: 10.1055/a-1975-0414
117
David Richards, Sajini Thekkel, William Ross. Oncologic Critical Care. 2019; : 1 doi: 10.1007/978-3-319-74698-2_176-1
118
Libin Wang, Shouchang Gai, Xiaorui Zhang, Xiaohui Xu, Nan Gou, Xingchen Wang, Nan Zhou, Tian Feng. Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC–MS/MS: application to pharmacokinetic interaction study. Bioanalysis 2020; 12(1): 11 doi: 10.4155/bio-2019-0130
119
Jillie Choi, Jae Eun No, Ju-Yeun Lee, Soo An Choi, Woo-Young Chung, Young-Mi Ah, Yun Mi Yu. Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovascular Drugs and Therapy 2022; 36(2): 333 doi: 10.1007/s10557-021-07171-5
120
Robert Benamouzig, Maxime Guenoun, David Deutsch, Laurent Fauchier. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants. Cardiovascular Drugs and Therapy 2022; 36(5): 973 doi: 10.1007/s10557-021-07211-0
121
NOAK als Sekundärprophylaxe für alle?. CardioVasc 2017; 17(4): 10 doi: 10.1007/s15027-017-1202-1
122
Syeda Ayesha Shah, Hasan Mushahid, Huda Ahmed. Dabigatran for venous malformations: A call for a stringent approach. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2023; 11(5): 1083 doi: 10.1016/j.jvsv.2023.04.010
123
Dmitry S. Bordin, Maria A. Livzan, Olga V. Gaus, Sergei I. Mozgovoi, Angel Lanas. Drug-Associated Gastropathy: Diagnostic Criteria. Diagnostics 2023; 13(13): 2220 doi: 10.3390/diagnostics13132220
124
Wolfgang Fischbach, Jan Bornschein, Jörg C. Hoffmann, Sibylle Koletzko, Alexander Link, Lukas Macke, Peter Malfertheiner, Kerstin Schütte, Dieter-Michael Selgrad, Sebastian Suerbaum, Christian Schulz. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Zeitschrift für Gastroenterologie 2024; 62(02): 261 doi: 10.1055/a-2181-2225
125
Alex Choo, Alessia Bragagnolo, Siyaguna K. D. M. Ekanayake, Alaa Alghamry. Sustained resolution of anticoagulation related iron deficiency anemia with the use of apixaban. Clinical Case Reports 2020; 8(1): 127 doi: 10.1002/ccr3.2585
126
Katherine A. Kelley, Karen J. Brasel. Emergency General Surgery. 2019; : 303 doi: 10.1007/978-3-319-96286-3_25
127
Bo Min Jang, Ok Sang Lee, Eun Jeong Shin, Eun Jeong Cho, Sung Yeon Suh, Yoon Sook Cho, Myung Koo Lee, Sandy Jeong Rhie. Factors related to inappropriate edoxaban use. Journal of Clinical Pharmacy and Therapeutics 2019; 44(5): 760 doi: 10.1111/jcpt.12999
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345